menu
    • menu

    Company profile for Ovid Therapeutics

    NEW Drugs in Dev: 8
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ovid Therapeutics Inc. is a New York-based biopharmaceutical company using its BoldMedicine® approach to develop medicines that transform the lives of patients with rare neurological disorders. Ovid has a broad pipeline of potential first-in-class medicines. The company’s most advanced investigational medicine, OV101 (gaboxadol), is currently in clinical development for the treatment of Angelman syndrome and Fragile X syndr...
    Ovid Therapeutics Inc. is a New York-based biopharmaceutical company using its BoldMedicine® approach to develop medicines that transform the lives of patients with rare neurological disorders. Ovid has a broad pipeline of potential first-in-class medicines. The company’s most advanced investigational medicine, OV101 (gaboxadol), is currently in clinical development for the treatment of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 (soticlestat) in collaboration with Takeda Pharmaceutical Company Limited for the potential treatment of rare developmental and epileptic encephalopathies (DEE).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ovid TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    New York, NY 1460 Broadway New York, NY 10036
    Telephone
    Telephone
    (646) 661-7661
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ovidrx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/10062052/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/OvidRx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    IMCAS Asia

    IMCAS Asia

    Not Confirmed

    envelop Contact Supplier

    IMCAS Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ovid Therapeutics to Participate in Upcoming Investor Conferences
    Ovid Therapeutics to Participate in Upcoming Investor Conferences

    04 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/04/3306625/0/en/ovid-therapeutics-to-participate-in-upcoming-investor-conferences.html

    GLOBENEWSWIRE
    04 Jun 2026
    Share Share
    Ovid Therapeutics Appoints Anna Greka, M.D., Ph.D., to Board
    Ovid Therapeutics Appoints Anna Greka, M.D., Ph.D., to Board

    03 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/03/3305900/0/en/ovid-therapeutics-appoints-leading-physician-scientist-and-biotech-innovator-anna-greka-m-d-ph-d-to-board-of-directors.html

    GLOBENEWSWIRE
    03 Jun 2026
    Share Share
    Ovid Pharma Hosts KCC2 R&D Deep Dive on April 14
    Ovid Pharma Hosts KCC2 R&D Deep Dive on April 14

    08 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/08/3270078/0/en/Ovid-Therapeutics-to-Host-Potassium-Chloride-Co-transporter-2-KCC2-Deep-Dive-R-D-Event-on-Tuesday-April-14.html

    GLOBENEWSWIRE
    08 Apr 2026
    Share Share
    Ovid Therapeutics Prices $60M Private Placement
    Ovid Therapeutics Prices $60M Private Placement

    18 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/18/3257973/0/en/Ovid-Therapeutics-Announces-Pricing-of-60-Million-Private-Placement.html

    GLOBENEWSWIRE
    18 Mar 2026
    Share Share
    Ovid Therapeutics Announces OV329 Data, OV4071 Clearance
    Ovid Therapeutics Announces OV329 Data, OV4071 Clearance

    18 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/18/3257984/0/en/Ovid-Therapeutics-Announces-New-OV329-Data-and-Indication-Expansion-Phase-1-Clearance-for-OV4071-and-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    18 Mar 2026
    Share Share
    Ovid Therapeutics To Participate In Upcoming Investor Conferences
    Ovid Therapeutics To Participate In Upcoming Investor Conferences

    25 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/25/3244468/0/en/Ovid-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    25 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search